EXEL vs SAIL Comparison

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

SailPoint Inc delivers solutions to enable comprehensive identity security for the enterprise. The company does this by unifying identity data across systems and identity types, including employee identities, non-employee identities, and machine identities. The SaaS and customer-hosted offerings of the company leverage intelligent analytics to give organizations critical visibility into which identities currently have access to which resources, which identities should have access to those resources, and how that access is being used. Its solutions enable organizations to establish, control, and automate policies that help them define and maintain a robust security posture and achieve regulatory compliance.